Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EP-0057 by Ellipses Pharma for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
EP-0057 is under clinical development by Ellipses Pharma and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...
Data Insights
EP-0057 by Ellipses Pharma for Epithelial Ovarian Cancer: Likelihood of Approval
EP-0057 is under clinical development by Ellipses Pharma and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData,...